Improving Outcomes After Relapse in Ewing's Sarcoma
Author Information
Author(s): Anne M. McTiernan, Anna M. Cassoni, Deirdre Driver, Maria P. Michelagnoli, Anne M. Kilby, Jeremy S. Whelan
Primary Institution: University College Hospital
Hypothesis
What factors are associated with improved survival in patients with relapsed Ewing's sarcoma?
Conclusion
Selective patients with aggressive treatment can achieve improved survival after relapse in Ewing's sarcoma.
Supporting Evidence
- 2-year post-relapse survival was 23.5% and 5-year was 15.2%.
- Patients with local or lung metastases had better survival rates.
- High-dose therapy at relapse significantly improved survival outcomes.
Takeaway
This study found that some patients with Ewing's sarcoma can live longer after their cancer comes back if they get strong treatments.
Methodology
A retrospective analysis of 114 patients with relapsed Ewing's sarcoma was conducted to identify factors associated with improved survival.
Potential Biases
Potential selection bias due to the retrospective nature of the study.
Limitations
As a retrospective analysis, it cannot control for selection bias.
Participant Demographics
61 males and 53 females, median age 19 (range, 4–48).
Statistical Information
P-Value
<0.001
Confidence Interval
95% CI: 0.17–0.58
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website